Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07420933 · ClinicalTrials.gov registry record · NA
Pea vs Whey Protein Supplementation With Resistance Training on Young Adults' Strength, Body Composition, and Metabolic Parameters
A NA study of Healthy Subjects, sponsored by Texas Woman's University.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
- 1
- Study location
NCT07420933: Completed NA study of Healthy Subjects, sponsored by Texas Woman's University.
NCT07420933 is a NA study of Healthy Subjects that has completed, run by Texas Woman's University. The registered enrollment target is 34 participants, below the 128-participant average among 69 other Healthy Subjects trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07420933, a NA study of Healthy Subjects, has completed, sponsored by Texas Woman's University.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to compare the impact of pea protein or whey protein supplementation during a progressive resistance exercise (PRE) regimen on body composition and strength in young adults who are not undergoing regular strength training. The main questions it aims to answer are: 1. Do lean body mass changes differ between supplement groups following a progressive resistance exercise PRE training program? 2. Does improvements in muscle strength differ between groups following a PRE training program? 3. Does glucose, insulin, and essential amino acid appearance and clearance rate differ between groups following a PRE training program? Researchers will compare pea protein supplementation to whey protein supplementation to see if there are any differences in body composition and strength Participants will: * Consume Pea or Whey protein supplement twice daily for 8 weeks * Participate in a PRE training program twice weekly for approximately 1.5 hours per day
Primary Outcome
Differences in lean mass (kg, kg/m\^2, and % total mass) and fat mass (kg, and % total mass) assessed using Dual Energy X-ray Absorptiometry (DXA; Horizon W, Hologic, Marlborough, MA)
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Protein Isolate
- BEHAVIORAL Progressive Resistance Exercise Training (PRE)
Study Locations (1)
Texas
- Texas Woman's University Institute of Health Sciences Houston Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2024-02-03 |
| Est. Completion | 2025-12-06 |
| Phase | NA |
What the finished NCT07420933 record still lists
NCT07420933 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 128-participant average among 69 other Healthy Subjects trials with a reported enrollment target (73% lower).
The record links to 1 condition, with Healthy Subjects appearing as the primary indexed condition, and to 2 interventions - of which Protein Isolate is the first listed.
NCT07420933 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT07420933 about?
NCT07420933 is a clinical study titled "Pea vs Whey Protein Supplementation With Resistance Training on Young Adults' Strength, Body Composition, and Metabolic Parameters". The goal of this clinical trial is to compare the impact of pea protein or whey protein supplementation during a progressive resistance exercise (PRE) regimen on body composition and strength in young adults who are not undergoing regular strength training. The main questions it aims to answer are: ...
What is the current status of trial NCT07420933?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2024-02-03. Estimated completion is 2025-12-06.
What conditions does trial NCT07420933 study?
This clinical trial studies the following conditions: Healthy Subjects.
What interventions are being tested in trial NCT07420933?
The interventions under investigation include: Protein Isolate (DIETARY_SUPPLEMENT), Progressive Resistance Exercise Training (PRE) (BEHAVIORAL).
Who is sponsoring clinical trial NCT07420933?
This trial is sponsored by Texas Woman's University, which has 51 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07420933 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Subjects
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07420933's enrollment target sits among peer trials
34 33rd of 69 higher than 37 of 69 other Healthy Subjects trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy Subjects trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Optimizing Ultrasound-induced Anti-inflammation in Human Subjects
RECRUITING · NA
-
The Short-term Verbal Memory Endophenotype for Developmental Language Disorder Language Disorder
RECRUITING · NA
-
Echography Study_Anthropometric Measurements
RECRUITING · NA
-
Avocado and Postprandial Responses
RECRUITING · NA
-
Auditory Prediction and Error Evaluation in the Speech of Individuals Who Stutter
RECRUITING · NA
-
In-Person Recruitment of Individuals to the Alzheimer's Prevention Trial (APT) Webstudy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI